ALOX15 and colitis: We found that Alox15-KI mice developed less intense inflammatory symptoms in the dextran-sulfate-sodium (DSS) induced colitis model and that this protective effect was paralleled by higher colon tissue concentrations of the specialized pro-resolving mediator (SPM) resolvin D5 in the Alox15-KI mice.